SCHEMBL470920

SCHEMBL470920

Cc1ccc(NC(=O)c2nccs2)cc1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 8/20 0.60
NPC1 O15118 6/20 0.55
RAB9A P51151 6/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
MAPT P10636 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.49
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
LMNA P02545 1/20 0.48
AGER Q15109 1/20 0.48
PPIA P62937 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6011016 0.89 GRM4 (0.58) GRM4NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL6655345 0.84 KMT2A (0.61) GRM4NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1091625 0.84 GRM4 (0.56) GRM4NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL168594 0.83 GRM4 (0.63) GRM4NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL12181073 0.83 ALDH1A1 (0.58) GRM4SMN1; SMN2KDM4EALDH1A1CASP3
SCHEMBL6660832 0.82 GRM4 (0.60) GRM4NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7361894 0.81 GRM4 (0.53) GRM4NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7125558 0.80 GRM4 (0.53) GRM4RAB9AMAPTKDM4EALDH1A1
SCHEMBL1091450 0.80 NAMPT (0.52) GRM4CASP3SENP8SENP7SENP6
SCHEMBL5164235 0.79 GRM4 (0.59) GRM4NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033069-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS 大鵬薬品工業株式会社 (JP) 2012-03-15 WO disclosed
EP-1442041-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-08-04 EP disclosed
WO-2003040147-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE__________________________________________________________________________________________________________________________ PHARMACIA & UPJOHN COMPANY (US) 2003-05-15 WO disclosed